Proses vaksinasi hepatitis B diberi

Proses vaksinasi hepatitis B diberikan melalui suntikan. Anti-HBs dapat muncul sebagai respon terhadap vaksinasi hepatitis B. Satu seri vaksinasi dapat membentuk antibodi yang cukup pada 95% orang sehat. Titer antibodi (anti-HBs) akan menurun seiring dengan umur imunisasi, yaitu pada umur lebih tua dan pada gangguan daya tahan tubuh akan menurun titer anti-HBs. Imunisasi pada bayi dan anak respons umumnya sangat baik dan menghasilkan titer anti-HBs yang tinggi walaupun dengan dosis yang lebih rendah dari orang dewasa. Diperkirakan antibodi hepatitis B (anti-HBs) dapat bertahan dalam tubuh lebih dari 5 tahun. Perlindungan dalam 5 tahun pertama kehidupan sudah cukup baik untuk mengurangi jumlah pengidap kronik, sekalipun booster tidak diberikan

Hasil (Inggris) 1:

The process of hepatitis B vaccinations given through injections. Anti-HBs can emerge as a response to hepatitis B vaccination. A series of vaccinations can form antibodies that enough on 95% of healthy people. Titer antibodies (anti-HBs) will decreases with age, immunization of older age and disturbance of body durability will decrease the anti-HBs titer. Immunization in infants and children are generally very good response and produce anti-HBs titer is high though with a lower dose than adults. Estimated hepatitis B antibodies (anti-HBs) can persist in the body for more than 5 years. Protection in the first 5 years of life was already good enough to reduce the number of people with chronic, though not given a booster

Hasil (Inggris) 2:

The process of hepatitis B vaccine is given by injection. Anti-HBs may arise in response to vaccination against hepatitis B. The vaccination series can form sufficient antibodies in 95% of healthy people. Titer antibody (anti-HBs) declines with age immunization, ie at an older age and in impaired resistance will decrease titer of anti-HBs. Immunization in infants and children are generally very good response and produce anti-HBs titers were high even with lower doses than adults. It is estimated that hepatitis B antibody (anti-HBs) can persist in the body over 5 years. Protection within the first 5 years of life has been good enough to reduce the number of people with chronic, even if the booster was not given